• Non ci sono risultati.

COMPANY OVERVIEW. Page 3

N/A
N/A
Protected

Academic year: 2022

Condividi "COMPANY OVERVIEW. Page 3"

Copied!
21
0
0

Testo completo

(1)

Company Presentation - 26 March 2010

(2)

ƒ This Presentation of P/f Bakkafrost (the “Company”) has been prepared for a press meeting on 26 March 2010 in connection with the listing of the Company’s shares on Oslo Børs. The Presentation has been prepared solely for information purposes. Information contained will not be updated. The Presentation should be read and considered in connection with the information given orally during the meeting. The Presentation may not be distributed, reproduced or otherwise used without the consent of the Company.

ƒ The information contained herein does not purport to contain all information concerning the Company. No party has made any kind of independent verification of any of the information set forth herein, including any statements with respect to projections or prospects of the business or the

assumptions on which such statements are based. The Company nor any of its subsidiaries, directors, officers or employees, make any representations or warranty, express or implied, as to the accuracy, reliability or completeness of this Presentation or of the information contained herein and shall have no liability for the information contained in, or any omissions from, this Presentation.

ƒ Included in this Presentation are various “forward-looking statements”, including statements regarding the intent, opinion, belief or current expectations of the Company or its management. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance and outcomes to be materially different from any future results,

performance or outcomes expressed or implied by such forward-looking statements, including, among others, risks or uncertainties associated with the Company’s business, segments, development, growth management, financing, market acceptance and relations with customers, and, more generally, general economic and business conditions, changes in domestic and foreign laws and regulations, taxes, changes in competition and pricing

environments, fluctuations in currency exchange rates and interest rates and other factors. Should one or more of these risks or uncertainties

materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in this document. No information contained herein constitutes, or shall be relied upon as constituting, any advice relating to the future performance of the Company. The Company undertakes no obligation to publicly update or revise any forward-looking statements included in this Presentation.

(3)

Page 3

COMPANY OVERVIEW

(4)

Bakkafrost – The largest fish farming company on the Faroe Islands

Fish farms Hatcheries Slaughteries HQ/VAP

~75km

~110km

ƒ Largest salmon farming company on the Faroe Islands

ƒ ~60 % of harvest volumes

ƒ ~44 % of existing licenses

ƒ The result of the merger of Bakkafrost and Vestlax in 2010

ƒ Produced a total of c. 30,650 tonnes gwt in 2009

ƒ Revenues and EBIT* in 2009 of DKK 922 and 205 million (22%)

ƒ Controlling the value chain from smolt to VAP (value added products)

ƒ C. 450 employees

(5)

Page 5

Excellent conditions for cost effective farming

4 6 8 10 12 14 16

ºC

Dec Nov Oct Sep Aug Jul Jun May Apr Mar Feb Jan

Faroe Islands Norway (Trøndelag)

Average water temperatures 2002-2008

Source: Company material, Havforskningsinstituttet

Geography

Water

Location

Biomass

ƒ Faroese fjords provide separation between locations

ƒ Improves biological control and area management

ƒ Short distances between farming- and processing facilities

ƒ Biological sustainability setting the biomass target per license

ƒ No maximum allowed biomass per license as in Norway

ƒ Limited water temperature variation throughout the year between 6-12 degrees Celsius

ƒ Excellent water quality and circulation conditions

ƒ Efficient distribution to both the European- and US markets

(6)

A pure play salmon producer covering the entire value chain

ƒ 8 licenses

ƒ 5 operative hatcheries

ƒ 15 wholly owned licenses

ƒ Produced 30,650 tonnes gwt in 2009

ƒ Two slaughteries with capacities of 100 and 120 tonnes lwe per day with the current shift structure

ƒ Current production 44 tonnes gwt/day

ƒ Capacity of 60 tonnes gwt/day

Smolt Farming Slaughter VAP

(7)

Page 7

Increased focus on the highly profitable VAP operations

Fresh and frozen 4%

gutted trout*

19%

By-products

Fresh and frozen gutted salmon 42%

VAP 35%

Sales split 2009 by product

Note: Split by DKK

*Trout to be phased out during 2010

(8)

Ideally located between Europe and the US

(% of revenue 2009)

USA:

Mostly fresh and frozen gutted fish of high slaughter weight (strong demand from sushi market) No import toll on whole fish to the US market

Europe:

Mostly frozen portions to large supermarket chains such as Lidl and Carrefour

US 20%

3%

7%

9% 8%

15%

4%

20%

Ukraine

Russia

Other Europe

Denmark

Faroesetraders

France

Germany

1%

3%

5%

Other far east

Taiwan

Japan

C. 2-3 days of transport 2 times a week

(9)

Page 9

ƒ During the period 2001-2004 the Faroe Islands were severely struck by ISA outbreaks

ƒ New legislation and regulation was introduced ultimo 2003 known as “The Faroese Veterinary Model”:

ƒ Fallow periods between generations in farming and hatcheries

ƒ Immunisation and vaccination programs

ƒ Restricting movement of equipment

ƒ Restricting movement of fish

ƒ Density limits introduced

ƒ Brood stock facilities allowed on land only

ƒ Minimum distances between farms, hatcheries etc introduced

ƒ The model has resulted in one of the most predictable fish production environments in the world with low mortality levels

New legislation

An excellent regulatory farming environment

0 3 6 9 12

0%

10%

20%

30%

ISA outbreaks Mortality

2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998

Mortality ISA outbreaks

Disease leading to a back to square one for Faroe salmon industry

Source: Company material

(10)

Faroe Islands with a very competitive cost level

14 16 18 20 22 24 26 28

NOK

2005 2006 2003 2004

2001 2002 2007 2008 2009E 2010E

Faroes Norway Chile

Source: Kontali, Nordea Markets

Cost/Kg gwt (NOK)

Very positive development in production cost - especially after the introduction of the Faroese Veterinary Model

The Faroe Islands currently have very low production

costs for Atlantic Salmon

(11)

Page 11

Bakkafrost with superior operational track record compared with industry peers

Mortality

0%

10%

20%

30%

40%

1994 1996 1998 2000 2002 2004 2006 2008

Norway avg.

Bakkafrost Faroes

Slaughter weight

4.0 4.5 5.0 5.5 6.0 6.5

1994 1996 1998 2000 2002 2004 2006 2008 kg wfe

Norway Bakkafrost Faroes

Economic feed conversion rate

1.0 1.1 1.2 1.3 1.4

1994 1996 1998 2000 2002 2004 2006 2008 Bakkafrost Norway

Faroes

Productivity

2 3 4 5 6

1994 1996 1998 2000 2002 2004 2006 2008 kg wfe per smolt

Norway Bakkafrost Faroes

Source: Company material, Fiskeridirektoratet, Kontali

(12)

20 12 31

49 64

108 109

327

0 50 100 150 200 250 300 350

‘000 tonnes gwt

Marine Farms Lighth.

Caledonia Bakkafrost

Grieg Seafood SalMar

Cermaq Leroy

Seafood Marine

Harvest

Strong fundamentals result in ‘best in class’ profitability

Volumes 2009

Source: Companies’ Q4 2009 reports

EBIT/kg gwt Q4 2009 (NOK)

14.2

11.5 10.5 8.68.9

5.96.1 5.55.9 4.95.1 4.8 4.44.8 4.34.3 3.9 3.83.9 3.0 1.7 1.0

Bakkafrost (North)

Bakkafrost post merger

Salmar Central Norway

Ley Seafood Group ASA

Vestlax

Norskott Havbruk

Lighthouse Caledonia ASA

GSF Shetland

Cermaq Mainstream Norwa

Marine Harvest Scotland

Marine Harvest ASA

Cermaq Mainstream Scotland

GSF Finnmark

Marine Harvest Canada

GSF Rogaland

Marine Harvest Norway

Grieg Seafood ASA

Marine Farms Lakeland

Cermaq Mainstream

Cermaq Mainstream Chile

Cermaq Mainstream Canada

Salmar Northern Norway

GSF BC (Canada)

-1.6

(13)

Page 13

Strong expected volume growth in existing licenses

1.4 1.4

3.2 0.7

2007 5.5

3.3 0.8

7.5

2011E 4.5 3.0

2010E 7.0

3.6 3.4

2009PF 6.3

3.9 2.1 0.3

2008 5.3

+42%

Bakkafrost Vestlax

Vestlax trout

ƒExpects to release 42% more smolt in 2011 than 2008

ƒNo absolute biomass restrictions

ƒVestlax trout to be phased out

Smolt release (million)

(14)

Attractive synergy potential from integrating the operations of Bakkafrost and Vestlax

1. Streamlining Vestlax operations to achieve Bakkafrost efficiency

ƒ Feed prices

ƒ Financing (not affecting EBIT)

ƒ Slaughteries

ƒ Manpower

14.2

8.9

6.2

10.5

8.6

2.4 2.6

8.4

0 5 10 15

Q409 Q309

Q209 Q109*

NOK

+5.6 Vestlax

Bakkafrost

EBIT/Kg gwt

2. Improving utilisation of the Group’s very profitable VAP facilities

27%

Unused capacity

Utilisation of current VAP facilities

*Excludes net non-operational losses of DKK 16.9m in Vestlax

(15)

Page 15

INDUSTRY OUTLOOK

(16)

Global supply shortage combined with increasing demand for salmon yields a positive market short term

2002

2001

million tonnes wfe

0.9

0.6

0.3 1.5

1.2

0.0

-8%

Norway Chile UK Canada Other Faroe Islands

2011

2010

2009

2008

2007

2006

2005

2004

2003

Source: Kontali, Nordea Markets

Global supply of Atlantic salmon

0 1 2 3 4

Kg

CAGR +9%

EU US Russia Japan

2008

2007

2006

2005

2004

2003

2002

2001

2000

1999

1998

1997

1996

1995

Per capita consumption of Atlantic Salmon

Source: Kontali

(17)

Page 17

FINANCIALS

(18)

Profit and Loss - Pro Forma 2009

Years ended 31 December Bakkafrost Pro Forma

Adjustments Bakkafrost IFRS

Vestlax IFRS

(DKK million) 2009 2009 2009

Operating income 922 -43 597 368

Operating expenses -689 43 -417 -314

Operating profit before deprec. and fair

value adjustments of biological assets 233 0 179 54

-margin 25.3% 30.0% 14.6%

Other income 10 0 0 10

Depreciation and amortisation -38 0 -21 -17

Operating profit before fair value

adjustments of biological assets 205 0 159 46

-margin 22.2% 26.6% 12.5%

Fair value adjustments of biological assets 34 0 34 1

Operating profit 239 0 192 47

-margin 26.0% 32.2% 12.8%

Financial income 3 -2 3 2

Financial cost -42 0 -14 -28

Profit before income tax 201 -1 181 21

(19)

Page 19

Balance Sheet - Pro Forma 2009

Years ended 31 December Bakkafrost Pro Forma

Adjustments Bakkafrost IFRS

Vestlax IFRS

(DKK million) 2009 2009 2009 2009

Assets

Intangible assets 136 68 0 69

Tangible non current assets 331 0 231 100

Financial non current assets 16 -16 26 6

Long term receivables 0 0 0 0

Total non-current assets 484 52 258 175

Biological assets 330 0 227 102

Inventories 25 0 21 4

Accounts receivables 114 -5 67 53

Other current receivables 15 0 13 2

Cash and cash equivalents 36 0 35 0

Total current assets 520 -5 363 162

Total Assets 1,004 46 621 337

Liabilities and shareholders’ equity

Share capital and share premium 91 -124 90 125

Retained earnings 483 152 299 32

Total shareholders' equity 573 28 389 157

Long term interest bearing debt 66 -5 34 37

Deferred taxes 76 24 57 -5

Total long-term liabilities 142 19 91 32

Short term interest bearing debt 215 0 98 117

Other short term liabilities 73 0 42 31

Total short-term liabilities 289 0 141 148

Total liabilities 431 19 232 180

Total shareholders' equity and 1,004 46 621 337

Equity ratio 57.1%

Net debt / EBITDA 1.1x

Interest coverage (EBITDA / financial cost) 5.6x

Source: Annual report 2009

(20)

Cash Flow – Pro Forma 2009

Years ended 31 December Bakkafrost

Pro Forma

Adjustments Bakkafrost IFRS

Vestlax IFRS

(DKK million) 2009 2009 2009

Cash Flow from Operations

Operating profit for the period 239 0 192 47

Depreciation 38 0 21 17

Adjustment for fair Value adjustment on biomass -34 0 -34 -1

Taxes paid 0 0 0 0

Change in inventories 106 0 33 73

Change in other current assets -28 5 -23 -10

Change in current debt -92 1 -1 -93

Net cash flow from operations 229 7 189 33

Cash Flow from investment activities

Proceeds from sale of fixed assets 0 0 0 0

Purchase of fixed assets -37 0 -21 -16

Purchase of shares -9 3 -12 0

Change in long term receivables 7 0 7 0

Net cash flow from investment activities -40 3 -27 -16

Cash Flow from financing activities

Repayments of borrowings -122 -5 -111 -6

Received interests 3 -2 3 2

Paid interests -42 -3 -14 -25

Payment of dividend -5 0 -5 0

Net cash flow from financing activities -165 -10 -127 -28

Net change in cash and cash equivalents 24 0 35 -11

(21)

Page 21

Riferimenti

Documenti correlati

While there is no evidence of a productivity dierential between Polizia and Cara- binieri for the very rst robbery of a sequence, subsequent robberies that fall in the Polizia

Dall’’altra parte, è possibile misurare l’’impatto della sintassi sulla traduzione lan- ciando tre istanze dello stesso motore di traduzione sullo stesso corpus: la prima non ha

Fra le tante persone di origine africana che vivono nel paese ci sono alcuni che si sono arresi di fronte ai pregiudizi delle persone e, in un certo senso, hanno deciso di

Dalla nostra analisi è evidente come i valori assoluti di Tg, fondamentali nel follow-up dei pazienti trattati con tiroidectomia totale e terapia radiometabolica

Findings from empirical studies of clients suggest that personal characteristics (personal and family background, self-perception, perceptions of women, sexual

Simulated IM3/C (both upper and lower) and 2-tone PAE as function of output power for 2GHz amplifier with 2 nd harmonic BPF preceding the shorted shunt input frequency O/4

Ci sono inoltre dei costi che possiamo considerare come diretti, che vengono direttamente imputati al costo del paziente, come le prestazioni sul paziente e la somministrazione

We received many enthusiastic responses as can be specifically seen from the papers that appear in the first issues of the journal, as well as the respected names listed in the